188 related articles for article (PubMed ID: 6792284)
1. Polyethylene glycol enhances the binding of C1q to circulating immune complexes.
Hack CE; Eerenberg-Belmer AJ; Hannema AJ; Out TA; Aalberse RC
J Immunol Methods; 1981; 44(2):211-21. PubMed ID: 6792284
[TBL] [Abstract][Full Text] [Related]
2. Enhancement of the binding of C1q to immune complexes by polyethylene glycol.
Wines BD; Easterbrook-Smith SB
Mol Immunol; 1988 Mar; 25(3):263-6. PubMed ID: 3259672
[TBL] [Abstract][Full Text] [Related]
3. Circulating immune complex-like materials which bind to heat inactivated C1q interfere with the C1q solid phase assay for immune complexes.
Fukuda K; Seino J; Kinoshita Y; Sudo K; Horigome I; Saito T; Furuyama T; Yoshinaga K
Tohoku J Exp Med; 1985 Aug; 146(4):449-56. PubMed ID: 3907015
[TBL] [Abstract][Full Text] [Related]
4. Relationship between renal pathology and the size of circulating immune complexes in patients with systemic lupus erythematosus.
Wener MH; Mannik M; Schwartz MM; Lewis EJ
Medicine (Baltimore); 1987 Mar; 66(2):85-97. PubMed ID: 3102894
[TBL] [Abstract][Full Text] [Related]
5. The IgG detected in the C1q solid-phase immune-complex assay is not always of immune-complex nature.
Hack CE; Belmer AJ
Clin Immunol Immunopathol; 1986 Jan; 38(1):120-8. PubMed ID: 3484437
[TBL] [Abstract][Full Text] [Related]
6. Anti-C1q column: ligand specific purification of immune complexes from human serum or plasma. Analysis of the interaction between C1q and immune complexes.
Kilgallon W; Amlot PL; Williams BD
Clin Exp Immunol; 1982 Jun; 48(3):705-14. PubMed ID: 6811171
[TBL] [Abstract][Full Text] [Related]
7. Circulating immune complexes and rheumatoid arthritis.
Faaber P; Rijke Schilder TP; Capel PJ; Koene RA
J Rheumatol; 1985 Oct; 12(5):849-53. PubMed ID: 3878875
[TBL] [Abstract][Full Text] [Related]
8. Differential precipitation of the Clq subcomponent of the first complement component (C1) by polyethylene glycol from normal human serum and sera of patients with collagen diseases.
Van Dijk H; Van Voorst J; Jankowski IG; Imhof JW; Kerckhaert JA
Clin Exp Immunol; 1984 Aug; 57(2):495-501. PubMed ID: 6432386
[TBL] [Abstract][Full Text] [Related]
9. Correlation between circulating antigens detected by the radioimmunoprecipitation-polyethylene glycol assay (RIPEGA) and C1q-binding immune complexes in human schistosomiasis mansoni.
Santoro F; Prata A; Silva AE; Capron A
Am J Trop Med Hyg; 1981 Sep; 30(5):1020-5. PubMed ID: 6974508
[TBL] [Abstract][Full Text] [Related]
10. Platelet interactions with C1q in whole blood and in the presence of immune complexes or aggregated IgG.
Peerschke EI; Ghebrehiwet B
Clin Immunol Immunopathol; 1992 Apr; 63(1):45-50. PubMed ID: 1591882
[TBL] [Abstract][Full Text] [Related]
11. Circulating IgA immune complexes in patients with psoriasis.
Hall RP; Peck GL; Lawley TJ
J Invest Dermatol; 1983 Jun; 80(6):465-8. PubMed ID: 6602187
[TBL] [Abstract][Full Text] [Related]
12. C1q solid-phase radioimmunoassay: binding properties of solid-phase C1q and evidence that C1q-binding IgG complexes in systemic lupus erythematosus are not bound to endogenous C1q.
Uwatoko S; Aotsuka S; Okawa M; Egusa Y; Yokohari R; Aizawa C; Suzuki K
J Immunol Methods; 1984 Oct; 73(1):67-74. PubMed ID: 6436382
[TBL] [Abstract][Full Text] [Related]
13. [Circulating immune complexes, detection in human glomerulonephritis by the PEG-EDTA technique (author's transl)].
Laurent B; Gonthier R; Genin C; Toulon J; Laurent P; Sabatier JC; Berthoux FC
Pathol Biol (Paris); 1982 Mar; 30(3):141-6. PubMed ID: 6808442
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of anti-C1q capture assay for detecting circulating immune complexes and comparison with polyethylene glycol-immunoglobulin G, C1q-binding, and Raji cell methods.
Levinson SS; Goldman JO
J Clin Microbiol; 1987 Aug; 25(8):1567-9. PubMed ID: 2957387
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the soluble immune complexes that are detected by three different techniques.
van der Giessen M; The TH
Clin Immunol Immunopathol; 1986 Feb; 38(2):244-55. PubMed ID: 3484441
[TBL] [Abstract][Full Text] [Related]
16. Circulating immune complexes in the sera and ascites of hepatocellular carcinoma or chronic hepatitis patients.
Chen YM; Hu CP; Wong FH; Chen PH; Tsai YT; Lee SD; Liu JD; Chang CM
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1986 Feb; 19(1):34-45. PubMed ID: 3028719
[TBL] [Abstract][Full Text] [Related]
17. Circulating immune complexes in the serum in systemic lupus erythematosus and in carriers of hepatitis B antigen. Quantitation by binding to radiolabeled C1q.
Nydegger UE; Lambert PH; Gerber H; Miescher PA
J Clin Invest; 1974 Aug; 54(2):297-309. PubMed ID: 4847246
[TBL] [Abstract][Full Text] [Related]
18. Critical aspects of the 125I-C1q binding assay for detecting immune complexes in tumor patients.
Krieger G; Bause I; Kneba M; Kehl A; Nagel GA
J Clin Lab Immunol; 1984 Jun; 14(2):87-92. PubMed ID: 6611419
[TBL] [Abstract][Full Text] [Related]
19. Serial measurement of circulating immune complexes in healthy subjects.
Puskás E; Füst G; Angyal I; Nguyen-Chi-Phi ; Gergely J
Immunol Lett; 1982 Apr; 4(4):223-7. PubMed ID: 6807843
[TBL] [Abstract][Full Text] [Related]
20. Detection and partial characterization of immune complexes in patients with rheumatoid arthritis plus Sjogren's syndrome and with Sjogren's syndrome alone.
Yoshinoya S; McDuffy S; Alarcon-Segovia D; Pope RM
Clin Exp Immunol; 1982 May; 48(2):339-47. PubMed ID: 6980743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]